• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacologic studies of low-dose and high-dose continuous infusion cytosine arabinoside.

作者信息

Kufe D W, Spriggs D R, Griffin J D

出版信息

Semin Oncol. 1987 Jun;14(2 Suppl 1):149-58.

PMID:3473675
Abstract
摘要

相似文献

1
Pharmacologic studies of low-dose and high-dose continuous infusion cytosine arabinoside.低剂量和高剂量持续输注阿糖胞苷的药理学研究。
Semin Oncol. 1987 Jun;14(2 Suppl 1):149-58.
2
Continuous infusion high-dose cytosine arabinoside without anthracyclines as induction and intensification therapy in adults under age 50 with newly diagnosed acute myelogenous leukemia.持续输注大剂量阿糖胞苷且不联合蒽环类药物作为50岁以下新诊断急性髓系白血病成人患者的诱导和强化治疗
Semin Oncol. 1987 Jun;14(2 Suppl 1):58-63.
3
Rationales for a pharmacologically optimized treatment of acute nonlymphocytic leukemia with cytosine arabinoside.
Leukemia. 1990 Nov;4(11):790-6.
4
Treatment of relapsed or refractory AML with intermediate-dose arabinosylcytosine (ara-C): confirmation of the importance of ara-C triphosphate formation in mediating response to ara-C.用中剂量阿糖胞苷（ara-C）治疗复发或难治性急性髓系白血病（AML）：证实阿糖胞苷三磷酸形成在介导对阿糖胞苷反应中的重要性。
Leuk Lymphoma. 1993;10 Suppl:115-21. doi: 10.3109/10428199309149123.
5
Biochemical and cellular pharmacology of cytosine arabinoside.
Semin Oncol. 1985 Jun;12(2 Suppl 3):34-48.
6
Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy.
Clin Sci (Lond). 1981 Feb;60(2):191-8. doi: 10.1042/cs0600191.
7
Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson Hospital.在MD安德森医院开展的高剂量阿糖胞苷临床研究的进展
Semin Oncol. 1985 Jun;12(2 Suppl 3):98-104.
8
Calculation of individual dosage regimen of cytosine arabinoside (ara-C) based on metabolite levels in leukemic cells.基于白血病细胞中代谢物水平计算阿糖胞苷（ara-C）的个体给药方案。
Ther Drug Monit. 1994 Aug;16(4):375-9. doi: 10.1097/00007691-199408000-00007.
9
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.高剂量1-β-D-阿拉伯呋喃糖基胞嘧啶治疗期间白血病细胞中1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸积累的饱和度
Cancer Res. 1987 Jun 1;47(11):3005-11.
10
Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-C.大剂量阿糖胞苷治疗期间阿糖胞苷三磷酸（ara-CTP）蓄积的饱和现象：中等剂量阿糖胞苷的药理学依据。
Semin Oncol. 1987 Jun;14(2 Suppl 1):159-66.

引用本文的文献

1
In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity.原始细胞对白细胞介素-3、粒细胞-巨噬细胞集落刺激因子和粒细胞集落刺激因子的体外反应在个体急性髓系白血病患者中存在差异：刺激白血病克隆形成细胞的因素也会增强阿糖胞苷的细胞毒性。
Ann Hematol. 1994 May;68(5):225-32. doi: 10.1007/BF01737421.
2
In vitro evidence for dose-dependent cytotoxicity as the predominant effect of low dose Ara-C on human leukemic and normal marrow cells.
Cancer Chemother Pharmacol. 1989;23(2):87-94. doi: 10.1007/BF00273523.
3
Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens.阿糖胞苷在急性髓系白血病治疗中的作用：大剂量方案的作用及地位
Ann Hematol. 1991 Apr;62(4):119-28. doi: 10.1007/BF01702925.